Catalysts for change: the cellular neurobiology of psychedelics
Open Access
- 1 June 2021
- journal article
- research article
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 32 (12) , 1135-1144
Abstract
The resurgence of interest in the therapeutic potential of psychedelics for treating psychiatric disorders has rekindled efforts to elucidate their mechanism of action. In this Perspective, we focus on the ability of psychedelics to promote neural plasticity, postulated to be central to their therapeutic activity. We begin with a brief overview of the history and behavioral effects of the classical psychedelics. We then summarize our current understanding of the cellular and subcellular mechanisms underlying these drugs’ behavioral effects, their effects on neural plasticity, and the roles of stress and inflammation in the acute and long-term effects of psychedelics. The signaling pathways activated by psychedelics couple to numerous potential mechanisms for producing long-term structural changes in the brain, a complexity that has barely begun to be disentangled. This complexity is mirrored by that of the neural mechanisms underlying psychiatric disorders and the transformations of consciousness, mood, and behavior that psychedelics promote in health and disease. Thus, beyond changes in the brain, psychedelics catalyze changes in our understanding of the neural basis of psychiatric disorders, as well as consciousness and human behavior.Keywords
This publication has 158 references indexed in Scilit:
- GPCR mediated regulation of synaptic transmissionProgress in Neurobiology, 2012
- Towards a glutamate hypothesis of depressionNeuropharmacology, 2012
- Arc in synaptic plasticity: from gene to behaviorTrends in Neurosciences, 2011
- Multiple receptors contribute to the behavioral effects of indoleamine hallucinogensNeuropharmacology, 2011
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effectsPsychopharmacology, 2011
- Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonistsNeuroscience Letters, 2011
- Experience-dependent structural synaptic plasticity in the mammalian brainNature Reviews Neuroscience, 2009
- Identification of a serotonin/glutamate receptor complex implicated in psychosisNature, 2008
- Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivoProceedings of the National Academy of Sciences, 2008
- Role of Gq protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropaneNeuropharmacology, 2007